Increase funding for surveillance and rapid response teams to monitor and contain emerging infectious diseases.
Pandemics
Pandemics Risk
Assessment for this date
The current pandemic risk is moderate, driven by rising flu and RSV activity, persistent COVID-19 impacts, and emerging infectious diseases like avian flu and MERS.
January 6, 2026
Trend
Viewing the record for January 6, 2026 within the full trend.
Risk Drivers
What is pushing the current reading.
The global pandemic risk remains moderate due to a combination of factors: increasing flu and RSV cases in the US and Europe, ongoing COVID-19 impacts despite vaccine availability, and emerging threats from avian flu and MERS. Surveillance and public health responses are challenged by misinformation and vaccine hesitancy, which complicate efforts to manage these diseases effectively. Additionally, the detection of new coronavirus subspecies and the persistence of long COVID symptoms indicate that the pandemic's long-term health effects are still unfolding. These issues highlight the need for sustained vigilance and adaptation in public health strategies.
Risk Reduction Actions
Priority actions generated from the current analysis.
Enhance public health communication to combat misinformation and improve vaccine uptake.
Accelerate studies on long COVID and its impacts to develop targeted treatments and interventions.
Support community outreach programs to educate the public on the importance of vaccination and preventive measures.
Facilitate global cooperation to address cross-border health threats and ensure equitable access to vaccines and treatments.
Sources Monitored
Visible feeds used in this category's nightly run.
Selected Articles
Supporting articles referenced in the latest score.
- US respiratory virus activity rises as Arkansas reports record pertussis year
- Study finds that despite broad COVID vaccine availability, COVID still deadlier than flu in hospitalized patients
- Flu, RSV activity rising in US and Europe, with major UK surge in flu cases
- US COVID, flu, and RSV levels low but rising in many regions
- First ever human case of H5N5 avian flu confirmed in Washington state